Limbic encephalitis: under-recognition of voltage-gated potassium channel antibodies.

lung cancer is associated with anti-Hu paraneoplastic LE. Since the report of Fukushima et al. [1] , we have shown the serum of their patient to be strongly positive for VGKC-Ab (2,354 p M ). The antibody titre decreased during treatment to 901 p M . This test is a radioimmunoassay utilising the binding of 125 I-radiolabelled -dendrotoxin to specific potassium channels. The results are expressed as picomoles of 125 I-dendrotoxin-VGKC-binding sites per litre of serum [3] . Results below 100 p M are considered negative, although we have found 5% of elderly subjects to have a titre between 100 and 400 p M [2] . Previously, we have demonstrated the presence of VGKC-Ab in two patients initially considered to have Hashimoto’s encephalopathy [3] . Hashimoto’s encephalopathy, in contrast to VGKC-Ab LE, often presents with prominent stroke-like episodes and frequent tremor. However, there is also some overlap: Hashimoto’s encephalopathy patients often have neuropsychiatric presentations, sleep disturbances, can show medial temporal lobe MRI abnormalities [4] , demonstrate thyroid hormone abnormalities and often show an excellent steroid response. These cases illustrate the need to consider VGKC-Ab-associated LE in the difDear Sir, Fukushima et al. [1] reported a case of steroid-responsive limbic encephalitis (LE) without clear aetiology. Their patient presented with generalised and complex partial seizures, amnesia, hyponatraemia and bilateral medial temporal lobe high signal on fluid-attenuated inversion recovery magnetic resonance images (MRI). This symptom myriad is best described within the rubric of LE. LE is traditionally considered a paraneoplastic phenomenon; hence the appropriately intensive search for occult malignancy by Fukushima et al. [1] . However, recently voltage-gated potassium channel antibodies (VGKC-Ab) have been shown to be a more reversible, infrequently malignant cause of LE [2] . The patient described by Fukushima et al. [1] also demonstrated prominent hormonal abnormalities, including the syndrome of inappropriate ADH (SIADH) and impaired thyrotropin-releasing hormone secretion. In keeping with this, previous descriptions of VGKC-Ab-associated LE have reported SIADH (in 80% of cases), significant appetite and weight gain (in 30%) and occasional abnormal thyroid function. However, SIADH is not a specific feature for VGKC-Ab-associated LE, since ADH is secreted from some small cell lung cancers, and 1% of all small cell Received: December 20, 2006 Accepted: February 9, 2007 Published online: July 2, 2007